Burning Rock Biotech Limi... (BNR)
NASDAQ: BNR
· Real-Time Price · USD
3.08
-0.09 (-2.84%)
At close: May 30, 2025, 3:55 PM
3.10
0.65%
After-hours: May 30, 2025, 04:00 PM EDT
Burning Rock Biotech Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Product Revenue | 225.08M | 192.41M | 234.99M | 215.71M | 154.57M |
| Product Revenue Growth | +16.98% | -18.12% | +8.94% | +39.56% | n/a |
| Service Revenue | 290.74M | 345.03M | 511.45M | 435.87M | 391.32M |
| Service Revenue Growth | -15.74% | -32.54% | +17.34% | +11.38% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| China Revenue | 510.24M | 534.93M | 553.3M |
| China Revenue Growth | -4.62% | -3.32% | n/a |
| United States Revenue | 5.58M | 2.51M | n/a |
| United States Revenue Growth | +122.62% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 84.02M | 81.28M | 141.7M | 145.54M | 171.32M | 181.03M | 140.37M | 192.81M | 217.88M | 233.81M | 255.95M | 230.94M | 244.78M | 192.99M | 184.19M | 171.39M | 171.11M | 146.91M | 80.26M | 64.11M | 98.22M | 73.47M | 55.54M | 58.26M | 60.7M |
| Selling, General, and Administrative Revenue Growth | +3.36% | -42.64% | -2.64% | -15.05% | -5.37% | +28.97% | -27.20% | -11.50% | -6.81% | -8.65% | +10.83% | -5.65% | +26.84% | +4.78% | +7.47% | +0.16% | +16.48% | +83.03% | +25.20% | -34.73% | +33.68% | +32.28% | -4.66% | -4.02% | n/a |
| Research and Development Revenue | 52.2M | 49.15M | 64.95M | 65.98M | 73.12M | 83.7M | 95.78M | 94.42M | 100.83M | 109.43M | 92.11M | 119.5M | 112.72M | 69.65M | 108.07M | 77.41M | 83.42M | 69.33M | 71.18M | 40.02M | 52.24M | 38.28M | 34.99M | 31.43M | 32.33M |
| Research and Development Revenue Growth | +6.21% | -24.33% | -1.57% | -9.76% | -12.64% | -12.61% | +1.44% | -6.36% | -7.86% | +18.80% | -22.92% | +6.01% | +61.85% | -35.55% | +39.60% | -7.20% | +20.32% | -2.59% | +77.87% | -23.40% | +36.47% | +9.39% | +11.34% | -2.78% | n/a |
| Sales and Marketing Revenue | 46.73M | 48.41M | 48.91M | 46.86M | 49.78M | 62.31M | 70.84M | 64.77M | 85.17M | 90.28M | 105.63M | 89.21M | 103.22M | 76.69M | 68.06M | 55.13M | 56.61M | 44.17M | 37.99M | 29.82M | 49.11M | 42.61M | 34.93M | 26.69M | 36.04M |
| Sales and Marketing Revenue Growth | -3.47% | -1.01% | +4.38% | -5.88% | -20.10% | -12.04% | +9.37% | -23.95% | -5.65% | -14.54% | +18.41% | -13.57% | +34.60% | +12.68% | +23.45% | -2.61% | +28.14% | +16.27% | +27.43% | -39.29% | +15.26% | +21.98% | +30.87% | -25.95% | n/a |